Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Follow-On Biologics Guidance Due In Spring; Woodcock Leads Effort

Executive Summary

FDA is planning to release a draft guidance on follow-on biologics in the spring

You may also be interested in...



Follow-On Proteins Draft Guidance Will Be Followed By Third Public Meeting

FDA will hold a third public forum on follow-on proteins shortly after the release of a draft guidance on the topic, Acting Deputy Commissioner of Operations Janet Woodcock said Feb. 14

Follow-On Proteins Draft Guidance Will Be Followed By Third Public Meeting

FDA will hold a third public forum on follow-on proteins shortly after the release of a draft guidance on the topic, Acting Deputy Commissioner of Operations Janet Woodcock said Feb. 14

FDA Generic Biologics “Structure” To Come Soon; Policy Debate In 2005

FDA hopes to be in a position to kick off a legislative and policy debate on the feasibility of "follow-on" biologics by the beginning of 2005

Related Content

UsernamePublicRestriction

Register

PS043203

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel